The reasoning was the impending commercialisation of the diabetes testing in the US with Sonic Healthcare as the exclusive diagnostic partner and the fact that there is an agreed reimbursement for the test to Sonic of which PIQ will receive a royalty stream.
For me in addition to above is the lure of a endometriosis test as the second key product. We have a family member afflicted by endo’ and this is a massive market which is crying out for early detection. In fact undiagnosed endo’ is a shocking factor that makes the impact of the disease so much worse for sufferers.
I hope that helps.
As an aside I generally steer away from bio-Pharma (my last experience was SRX a few years ago where I finally got out with a small gain). However the very near term commercialisation of the diabetes test and my reasonable knowledge of endo’ makes me confident to invest in PIQ.
Cheers…….D
- Forums
- ASX - By Stock
- PIQ
- PIQ $1.00
PIQ $1.00, page-43
-
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PIQ (ASX) to my watchlist
|
|||||
Last
91.5¢ |
Change
0.005(0.55%) |
Mkt cap ! $119.2M |
Open | High | Low | Value | Volume |
92.0¢ | 92.0¢ | 91.0¢ | $22.33K | 24.32K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3400 | 91.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.5¢ | 3603 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3400 | 0.915 |
2 | 12899 | 0.910 |
1 | 1070 | 0.905 |
4 | 15671 | 0.900 |
1 | 4000 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.925 | 3603 | 2 |
0.930 | 9502 | 2 |
0.935 | 3374 | 1 |
0.940 | 4205 | 1 |
0.950 | 71789 | 4 |
Last trade - 12.45pm 29/07/2024 (20 minute delay) ? |
Featured News
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
PIQ (ASX) Chart |